Theolytics raised £19m in funding from Sound Bioventures, M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises. Biotech Health services Pharma Investments 07 April 2024 Share:
Round value (USD): 24.15m Round investors: Epidarex Capital Merck Ventures Oxford Science Enterprises Taiho Ventures Sound Bioventures Company: Theolytics Industry: Biotech Health services Pharma
Aviado Bio in a $20M strategic equity deal with Astellas Pharma Biotech Health services Manufacturing Pharma Investments 02 October 2024
Enara Bio raised $32.5m in Series B funding co-led by Pfizer Ventures and M Ventures, joined by RA Capital, Samsara BioCapital, and SV Health Investors. Biotech Health services Pharma Investments 03 September 2024
LoQus23 raised £35M series A led by Forbion Partners, joined by SV Health Investors, Novartis Venture Fund and Dementia Discovery Fund Biotech Health services Manufacturing Investments 03 September 2024
CellCentric raised £27.2M with RA Capital Management Biotech Health services Manufacturing Investments 19 July 2024
Manual raised £29.2m with Felix Capital, Cherry Ventures, alongside new investor Octopus Ventures. Beauty Ecommerce Health services Mobile Pharma Investments 16 June 2024